Cistanche; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Hipoglucemiantes/uso terapéutico; Hipolipemiantes/uso terapéutico; Extractos Vegetales/uso terapéutico; Animales; Glucemia/análisis; Diabetes Mellitus Tipo 2/metabolismo; Glucógeno/metabolismo; Hipoglucemiantes/farmacología; Hipolipemiantes/farmacología; Resistencia a la Insulina; Lípidos/sangre; Hígado/metabolismo; Masculino; Ratones; Ratones Mutantes; Músculo Esquelético/metabolismo; Fitoterapia; Extractos Vegetales/farmacología; Tallos de la Planta

AB; Anti-hyperglycemic effect; BW; CT; Cistanche tubulosa; DM; Diabetes mellitus; FBG; FINS; Fasting Serum Insulin Level; HDL-c; HOMA-IR; Homeostatic Model Assessment of Insulin Resistance; Hypolipidemic effect; ITT; LDL-c; PPRC; PhGs; Pharmacopoeia of the People's Republic of China; RG; TC; TG; Type 2 diabetes; VLDL-c; acarbose; body weight; fasting blood glucose; high-density lipoprotein cholesterol; insulin tolerance test; low-density lipoprotein cholesterol; phenylethanoid glycosides; rosiglitazone; total cholesterol; triglycerides; very low-density lipoprotein cholesterol